Summary & Overview
CPT 3514F: Specific Clinical Performance Measure
CPT code 3514F represents a designated clinical or performance measure within the CPT coding system; the source description provided contains no additional summary. Such CPT entries are used in clinical documentation and billing to capture specific patient care items, services, or performance metrics that support quality measurement, reporting, or service identification. Nationally, clear identification of these codes matters for consistent claims submission, quality reporting, and interoperability across payers and providers.
Key payers in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find information on the code's purpose as a CPT entry, the limited available descriptive data, and guidance on what types of benchmarking and policy or clinical context are typically relevant when interpreting similar CPT performance or descriptor codes. The publication outlines where data is present and where input data is missing, and it will point readers toward typical next steps for obtaining complete code definitions, expected sites of service, and associated billing guidance from standard CPT resources and payer policies.
Billing Code Overview
CPT code 3514F has no summary available in the source description. Based on the code listing, this entry represents a specific clinical or performance measure within the CPT coding framework.
-
Service type: Data not available in the input.
-
Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting with progressive peripheral arterial disease of the lower extremity characterized by intermittent claudication, rest pain, non-healing ischemic ulceration, or acute limb ischemia. The clinical workflow begins with vascular clinic evaluation and noninvasive testing (ankle-brachial index, arterial duplex ultrasound, CT angiography or MR angiography) confirming an atherosclerotic lesion of the femoropopliteal or tibial arterial segments. The patient is scheduled for endovascular intervention in an outpatient vascular lab or hospital catheterization suite. Pre-procedure steps include informed consent, review of anticoagulation, intravenous access, and administration of conscious sedation or monitored anesthesia care. Under fluoroscopic guidance, arterial access is achieved (commonly via common femoral artery), selective catheterization and angiography are performed to localize the lesion, and angioplasty and/or stent placement is performed as indicated. Post-procedure care includes hemostasis (closure device or manual compression), vascular monitoring in recovery, discharge instructions, antiplatelet therapy management, and scheduled follow-up for wound care or duplex surveillance.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician’s professional interpretation component separate from technical services. |